GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 48 | 1,143 | 1,724 | 5,776 | 2,497 |
| Cost of Goods | 50 | 909 | 728 | 3,084 | 1,345 |
| Gross Profit | -2 | 234 | 996 | 2,692 | 1,152 |
| Operating Expenses | 1,204 | 2,354 | 3,003 | 5,446 | 4,686 |
| Operating Income | -1,156 | -1,211 | -1,279 | -2,670 | -3,189 |
| Interest Expense | 1,136 | 1,657 | 1,014 | 484 | 26 |
| Other Income | 46 | 159 | 2,670 | -1,666 | 108 |
| Pre-tax Income | -2,246 | -2,709 | 377 | -4,820 | -3,107 |
| Income Tax | N/A | 77 | 75 | 120 | 2 |
| Net Income Continuous | -2,246 | -2,786 | 302 | -4,940 | -3,109 |
| Net Income Discontinuous | N/A | -2,220 | 169 | N/A | N/A |
| Net Income | $-2,246 | $-5,006 | $471 | $-4,940 | $-3,109 |
| EPS Basic Total Ops | -0.05 | -0.11 | 0.01 | -0.11 | -0.07 |
| EPS Basic Continuous Ops | -0.05 | -0.06 | 0.01 | -0.11 | -0.07 |
| EPS Basic Discontinuous Ops | N/A | -0.05 | 0.00 | N/A | N/A |
| EPS Diluted Total Ops | -0.05 | -0.11 | 0.01 | -0.11 | -0.07 |
| EPS Diluted Continuous Ops | -0.05 | -0.06 | 0.01 | -0.11 | -0.07 |
| EPS Diluted Discontinuous Ops | N/A | -0.05 | 0.00 | N/A | N/A |
| EBITDA(a) | $-422 | $-408 | $-428 | $-2,203 | $-3,035 |